Antivert and Haemoglobin decreased - a phase IV clinical study of FDA data

Summary:

Haemoglobin decreased is reported as a side effect among people who take Antivert (meclizine hydrochloride), especially for people who are female, 60+ old, also take Aspirin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Antivert. It is created by eHealthMe based on reports of 3,935 people who have side effects when taking Antivert from the FDA, and is updated regularly.

What is Antivert?

Antivert has active ingredients of meclizine hydrochloride. It is often used in dizziness. eHealthMe is studying from 4,087 Antivert users. Check the latest studies of Antivert.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,408 drugs and 3,131 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

On Jul, 18, 2026

3,935 people reported to have side effects when taking Antivert.
Among them, 91 people (2.31%) have Haemoglobin decreased.

Could Antivert cause Haemoglobin decreased?

Among these 91 people:

What is the gender of people who have Haemoglobin decreased when taking Antivert? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Haemoglobin decreased when taking Antivert? *

What are other drugs people take besides Antivert? *

What are other side effects people have besides Haemoglobin decreased? *

Weakness: 39 people, 42.86%
Fall: 35 people, 38.46%
Urinary Tract Infection: 35 people, 38.46%
Pain: 33 people, 36.26%
Weight Decreased: 31 people, 34.07%
Neuropathy Peripheral (surface nerve damage): 29 people, 31.87%
Hypoaesthesia (reduced sense of touch or sensation): 28 people, 30.77%
Nausea (feeling of having an urge to vomit): 28 people, 30.77%
Fatigue (feeling of tiredness): 28 people, 30.77%
Bone Disorder: 26 people, 28.57%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 25 people, 27.47%
Pain: 19 people, 20.88%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 18 people, 19.78%
Stress And Anxiety: 16 people, 17.58%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 15 people, 16.48%
Bone Disorder: 14 people, 15.38%
Bone Pain: 14 people, 15.38%
Breast Cancer: 14 people, 15.38%
Anaemia (lack of blood): 14 people, 15.38%
Gout (uric acid crystals building up in the body): 14 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Antivert and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Antivert:

Antivert (4,087 reports)

Browse all side effects of Antivert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin decreased:

Haemoglobin decreased (2,408 drugs)

Browse all the conditions that are associated with Haemoglobin decreased:

Haemoglobin decreased (3,131 conditions)

Related publications that referenced our studies

Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .
Hassan JK, "POTENTIAL POSITIVE EFFECT OF ORAL PYRIDOXINE ALONE AND IN COMBINATION WITH MECLIZINE ON CIGARETTES SMOKING DURING TENDAYS’TRIAL", IJPSR, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on meclizine hydrochloride (the active ingredients of Antivert) and Antivert (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.